Replicative aging in yeast is asymmetric–mother cells age but their daughter cells are rejuvenated. Here we identify an asymmetry in pH between mother and daughter cells that underlies aging and rejuvenation. Cytosolic pH increases in aging mother cells, but is more acidic in daughter cells. This is due to the asymmetric distribution of the major regulator of cytosolic pH, the plasma membrane proton ATPase (Pma1). Pma1 accumulates in aging mother cells, but is largely absent from nascent daughter cells. We previously found that acidity of the vacuole declines in aging mother cells and limits lifespan, but that daughter cell vacuoles re-acidify. We find that Pma1 activity antagonizes mother cell vacuole acidity by reducing cytosolic protons. However, the inherent asymmetry of Pma1 increases cytosolic proton availability in daughter cells and facilitates vacuole re-acidification and rejuvenation.https://doi.org/10.7554/eLife.03504.001
Aging is a part of life—but its biological basis and, in particular, how aged cells give rise to young offspring (or progeny) has not been clearly established for any organism.
Budding yeast is a microorganism that is a valuable model to understand aging in more complex organisms like humans. Budding yeast cells undergo a process called ‘replicative aging’, meaning that each yeast mother cell produces a set number of daughter cells in her lifetime. However, when daughter cells arise from an aging mother cell, the daughter's age is ‘reset to zero’. How mother cells age, and how their daughters are rejuvenated, are questions that have been studied for decades.
Previously, researchers discovered that a mother cell's vacuole (an acidic compartment that stores important molecules that can become toxic) becomes less acidic as the mother cell ages. Daughter cells, on the other hand, have very acidic vacuoles, which was linked to their renewed lifespans. However, the mechanism behind this difference in the acidity of the vacuole between mother and daughter cells was unknown.
Now, Henderson et al. have found that a protein (called Pma1), which is found at the cell surface and pumps protons out of the cell, is present in mother cells but not in their newly-formed daughter cells. Furthermore, the Pma1 protein also accumulates as mother cells age. By pumping protons out of the cell, Pma1 effectively reduces the number of protons available to acidify the vacuole in the mother cell. However, because at first the daughter does not have Pma1, there are still plenty of protons inside the cell to acidify the vacuole.
When Henderson et al. reduced the activity of Pma1 in mother cells, the entire cell became more acidic, and so did their vacuoles. Conversely daughter cells engineered to have more Pma1 were less acidic and had less acidic vacuoles than normal.
Henderson et al. next asked whether reducing Pma1 activity to create a more acidic cell, could extend the lifespan of cells, and found that indeed cells with less Pma1 activity lived longer. As such, these findings indicate that an asymmetry in the acidity of the cell—caused by unequal levels of the Pma1 protein—contributes to reducing the lifespan of the mother cell and to rejuvenating the daughter cell. Thus Henderson et al. have identified one of the earliest events in the cellular aging process in budding yeast. Their findings suggest that an imbalance in an activity that is normally essential for cell survival (in this case, the activity of Pma1) can have long-term consequences for the cell that lead to aging.https://doi.org/10.7554/eLife.03504.002
During replicative aging in budding yeast, mother cells produce a finite number of daughter cells before arresting (Mortimer and Johnston, 1959). Because replicative aging is asymmetric, the process of aging occurs in mother cells but is absent in daughter cells (Egilmez and Jazwinski, 1989; Kennedy et al., 1994). Several asymmetric phenotypes have been identified and proposed to contribute to mother cell decline (Sinclair and Guarente, 1997; Lai et al., 2002; Aguilaniu et al., 2003; Erjavec et al., 2007; Eldakak et al., 2010; McFaline-Figueroa et al., 2011; Nystrom and Liu, 2014). We recently found that the acidity of the yeast lysosome-like vacuole is asymmetric between mother and daughter cells. Vacuole acidity declines in mother cells in early age and limits lifespan, but daughter cells have acidic vacuoles (Hughes and Gottschling, 2012). To identify what reduces vacuole acidity and how vacuole acidity is regenerated in daughter cells, we further characterized vacuole pH asymmetry. Cells were aged using a genetic system (Lindstrom and Gottschling, 2009) and vacuole acidity was monitored by staining cells with quinacrine, a fluorescent dye that accumulates in the acidic vacuole (Weisman et al., 1987). We observed bright vacuolar quinacrine staining indicative of acidic pH in a high percentage of buds (nascent daughter cells) regardless of mother cell age, whereas staining was diminished or undetectable in mother cell vacuoles (Hughes and Gottschling, 2012) (Figure 1A). Thus, throughout their lifespan mother cells produce daughter cells capable of regenerating vacuole acidity.
To further characterize vacuole pH asymmetry, the timing of re-acidification of the bud vacuole was examined. Vacuole acidity was asymmetric in cells treated with nocodazole (Figure 1B), suggesting that the bud vacuole re-acidifies prior to cytokinesis. We confirmed that re-acidification occurred before cytokinesis by examining cells containing the septin marker Cdc10-mCherry (Figure 1C). A single septin ring at the bud neck transitions to two rings during cytokinesis (Lippincott et al., 2001). We observed high vacuole acidity in buds when there was a single septin ring, further supporting that vacuole acidity regenerates prior to cytokinesis. Thus, throughout their lifespan, mother cells produce daughter cells that regenerate vacuole acidity prior to cytokinesis, when mother and daughter cells share a common cytosol. Thus, whatever causes the asymmetry of vacuole pH must also be asymmetric between mother and daughter cells prior to cytokinesis.
One of the major points of regulation of vacuole acidity is assembly of the vacuolar proton ATPase (V-ATPase), a multi-subunit complex that pumps protons from the cytosol into the vacuole. The V-ATPase consists of the integral membrane V0 complex and the V1 complex that associates with the V0 (Li and Kane, 2009). We examined whether there was a difference in vacuole-associated V1 or V0 between mother and daughter cells by visualizing green fluorescent protein (GFP) tagged subunits of each domain and found no evidence of asymmetry (Figure 1—figure supplement 1). Thus, no obvious difference in V-ATPase assembly can account for vacuole pH asymmetry between mother and bud.
In a screen to identify proteins asymmetrically retained in mother cells throughout aging, we identified the plasma membrane proton ATPase, Pma1 (Thayer et al., 2014). Pma1 is the major regulator of cytosolic pH (Ferreira et al., 2001; Serrano et al., 1986), and has similar activity to the V-ATPase, in that they both translocate cytosolic protons across membranes. Pma1 pumps protons from the cytosol out of the cell, whereas the V-ATPase pumps cytosolic protons into the vacuole (Orij et al., 2011). Because Pma1 regulates cytosolic pH, we hypothesized that it could antagonize vacuole acidity during aging and underlie vacuole pH asymmetry.
As a first step in testing our hypothesis, we analyzed Pma1 protein localization. There are conflicting reports on Pma1 asymmetry (Smardon et al., 2013; Khmelinskii et al., 2012; Malínská et al., 2003), however we found that Pma1 was asymmetric between mother and daughter cells. Pma1 levels at the plasma membrane were higher in mother cells than daughter cells as indicated by indirect immunofluorescence with antibody to Pma1 (Figure 2A). Similarly, Pma1 was more abundant in mother cells than buds when visualized with either Pma1-GFP (Figure 2A) or Pma1-mCherry fusion protein (Figure 2B). We also detected mCherry and GFP fluorescence in the vacuole, which likely represents misfolded protein directed to the vacuole for degradation (Chang and Fink, 1995). Importantly, we found that asymmetry of Pma1 at the plasma membrane was maintained through at least 18 mother cell divisions and that Pma1 was asymmetric prior to cytokinesis (Figure 2B), paralleling the asymmetry of vacuole pH.
When we examined Pma1 distribution during mother cell aging, we found that Pma1 increased at the plasma membrane in early age (Figure 2B). Pma1 levels were very low in newborn daughter cells, increased as daughter cells became mothers, and continued to increase over the first three mother cell divisions. This pattern of Pma1 abundance in daughters and aging mother cells inversely correlated with vacuole acidity. When Pma1 was very low in buds and newborn cells, the vacuole was acidic. In contrast, vacuole acidity was reduced in mother cells that have high Pma1 levels.
The inverse correlation between Pma1 levels and vacuole acidity suggested that Pma1 could cause vacuole pH asymmetry by antagonizing V-ATPase activity in mother cells. We first tested whether high levels of Pma1 could reduce vacuole acidity by overexpressing an extra copy of PMA1 in newborn daughter cells from an inducible promoter (Gao and Pinkham, 2000; Veatch et al., 2009). Overexpression of PMA1-mCherry increased Pma1 at the plasma membrane of newborn cells (Figure 3—figure supplement 1). Without excess Pma1, 87% of newborn cells had highly acidic vacuoles, whereas vacuole acidity was only high in 13% of cells upon PMA1 overexpression (Figure 3A). To further test whether Pma1 antagonized vacuole acidity, we reduced Pma1 activity and examined vacuole acidity in aging mother cells. PMA1 is an essential gene and cannot be deleted (Serrano et al., 1986), so we reduced its activity by 65% using the pma1-105 allele that has a mutation in the catalytic domain (McCusker et al., 1987; Perlin et al., 1989). In contrast to wild-type cells where vacuole acidity was reduced in more than 80% of cells in the third and subsequent mother cell divisions (Figure 3B), pma1-105 cells retained high vacuole acidity after 3 divisions and up to at least 18 divisions (84% and 79% respectively, Figure 3B). These results suggest that Pma1 activity antagonizes vacuole acidification and, combined with the expression pattern of Pma1, support the idea that increased Pma1 in aged mother cells causes the reduction of vacuole acidity.
We previously found that delaying the reduction of vacuole acidity during aging by increasing V-ATPase levels extends replicative lifespan (Hughes and Gottschling, 2012). Given the evidence presented above that Pma1 levels antagonize vacuolar acidity, we asked whether reduced Pma1 activity also affected lifespan. Indeed, the pma1-105 allele increased median replicative lifespan by ∼30% (Figure 3C), comparable to well-characterized lifespan-extending mutations (Delaney et al., 2011). The slope of the pma1-105 lifespan curve is similar to the slope of the wild-type curve. This suggests that instead of influencing the rate of aging throughout lifespan, the pma1-105 allele delays the onset of the normal aging process. To ascertain whether lifespan extension by the pma1-105 allele occurred entirely via increased vacuolar acidity, we examined the lifespan of pma1-105 cells that lacked V-ATPase function. Cells lacking the V-ATPase subunit Vma2 had a short median lifespan of 2 divisions, as previously reported (Hughes and Gottschling, 2012). The lifespan of cells that had reduced Pma1 activity and that were devoid of V-ATPase function (vma2Δ, pma1-105) was much shorter than wild-type lifespan (median 7 divisions), and more similar to cells lacking V-ATPase function. This suggests that most of the lifespan extension imparted by the pma1-105 allele requires V-ATPase function, but that the mechanism of lifespan extension is not limited to increased vacuolar acidification. Taken together these results support the idea that high Pma1 levels on mother cells impair vacuole acidification and limit lifespan.
In addition to Pma1 antagonizing mother cell vacuole acidity with age, we also hypothesized that the inherent asymmetry of Pma1, and thus low levels on buds, allows for re-acidification of the vacuole in buds. To test this idea, we asked whether expressing Pma1 in buds reduced vacuole acidity. We induced overexpression of PMA1-mCherry in cells arrested prior to cytokinesis with nocodazole and in untreated cells (Figure 3D). In untreated cells, overexpression increased mother cell Pma1 levels but maintained mother-bud asymmetry. However, in nocodazole-arrested cells, PMA1-mCherry became equivalently high in mother cells and buds. At least 80% of buds had acidic vacuoles without PMA1 induction or when PMA1 was induced in the absence of nocodazole (Figure 3E). In contrast, only 13% of buds had acidic vacuoles when Pma1 levels were high in buds. Because increased Pma1 levels in buds impaired re-acidification of the vacuole, we conclude that the inherent asymmetry of Pma1 is required for regeneration of vacuole acidity prior to cytokinesis. We speculate that regeneration of vacuole acidity is required for daughter cell rejuvenation and that if high levels of Pma1 were induced in the buds of aging mother cells, daughter cells would not rejuvenate.
We wondered how Pma1 antagonizes vacuole acidity and how low Pma1 levels in buds permit vacuole reacidification. Given that Pma1 pumps protons out of the cell, we hypothesized that increased Pma1 activity antagonizes vacuole acidity by reducing cytosolic protons available to the V-ATPase. A prediction of this hypothesis is that cytosolic pH may become more basic with age, and may differ between mother and daughter cells. To test this hypothesis, we examined cytosolic pH with ratiometric pHluorin (a pH-sensitive GFP) (Miesenbock et al., 1998) fused to a plasma membrane targeting sequence (residues 1–28 of the Psr1 protein) (Siniossoglou et al., 2000). With this reagent, cytosolic pH at the cell cortex was visualized (Figure 4A) and quantified in mother cells of varying ages and in their buds. Newborn daughter cells or mother cells that had undergone 1 or 2 divisions had a mean cytosolic pH of ∼7.1, similar to previous measurements of bulk log phase cultures (Orij et al., 2009) (Figure 4B). However, as mother cells aged, cortical cytosolic pH increased as much as ∼0.5 pH units (Figure 4B). Moreover, when we examined mother cells (on average 3 or 18 divisions old) and their attached buds, cortical pH was ∼0.2 or ∼0.1 pH units lower in buds than mother cells (Figure 4C). All together, these results indicate that cortical cytosolic pH increases during replicative aging and is asymmetric between mother and daughter cells. Mother-daughter asymmetry of cytosolic pH might be surprising given the rapid diffusion of protons (Wraight, 2006). However, local cytosolic pH differences have been observed in tumor cell invadopodia (Magalhaes et al., 2011) and cytosolic pH gradients can form during polarized growth (Feijo et al., 1999; Gibbon and Kropf, 1994).
To test whether Pma1 asymmetry was required for cortical cytosolic pH asymmetry, we modulated Pma1 levels and activity in mother cells and buds and monitored cytosolic pH. We overexpressed PMA1, which increased mother cell levels but maintained mother-bud asymmetry (as in Figure 3D), and we overexpressed PMA1 in nocodazole treated cells to generate equivalent high levels of Pma1 in mother cells and buds. Overexpression of PMA1 in mother cells alone elevated mother cell cytosolic pH by ∼0.7 pH units and increased the mother-bud difference in cytosolic pH by ∼0.5 pH units (Figure 4—figure supplement 1A). However, when Pma1 levels in buds were elevated to mother cell levels, bud pH increased, abrogating cytosolic pH asymmetry. Moreover, decreasing Pma1 activity with the pma1-105 allele decreased cortical cytosolic pH by ∼0.7 pH units (Figure 4—figure supplement 1B). Taken together our results suggest that the inherent asymmetry of Pma1 creates mother-daughter cytosolic pH asymmetry prior to cytokinesis.
Our findings support the idea that Pma1 activity antagonizes vacuole acidification via a competition with the V-ATPase for limited cytosolic protons (at pH 7 there are ∼3000 free protons per yeast cell, ∼106 Pma1 molecules and ∼105 V-ATPase V0 subunits) (Orij et al., 2011; Huh et al., 2003). While other modes of regulation may also be involved, our results can be explained by high Pma1 activity in aged mother cells translocating a sufficient number of protons out of the cytosol to restrict proton availability for the V-ATPase and reduce vacuole acidity (Figure 4D). Conversely, lower Pma1 activity in buds leads to more cytosolic protons and higher vacuole acidification.
Our findings identify increased cytosolic pH as an early contributing step to the aging process in budding yeast and suggest that cytosolic pH asymmetry facilitates daughter cell rejuvenation. Interestingly, this same discontinuity of cytosolic pH in plant and algae cells (Feijo et al., 1999; Gibbon and Kropf, 1994) and of Pma1 orthologs in fission yeast and pollen tubes (Minc and Chang, 2010; Certal et al., 2008) is conserved during polarized cell growth. We speculate that non-uniform cytosolic pH is generally important in polarized growth and has been co-opted in cell types that undergo asymmetric divisions to regenerate full cellular capacity.
Yeast strains are listed in Supplementary file 1. All strains are derivatives of Saccharomyces cerevisiae S288c (BY) (Brachmann et al., 1998). One-step PCR-mediated gene replacement and epitope tagging were performed using standard techniques, with template plasmids pRS306, pRS400, pKT127 and pKTmCherryKanMX (Sheff and Thorn, 2004; Sikorski and Hieter, 1989). Oligonucleotides for gene replacement, tagging, and cloning are listed in Supplementary file 1.
Strains expressing Vma2–GFP were derived from the yeast GFP collection (Huh et al., 2003). The Gal4-Estrogen binding domain-VP16 (GEV) fusion protein (Veatch et al., 2009) was integrated into the leu2Δ0 allele by transforming PmeI-linearized pAGL plasmid. Strains expressing PMA1 or PMA1-mCherry from a GAL promoter were constructed by transformation of GEV yeast strains with NotI-digested pAG306-GAL-PMA1 chr1 or pAG306-GAL-PMA1-mCherry chr1, which integrated them into an empty region of chromosome 1 (199456–199457) (Hughes and Gottschling, 2012).
The pma1-105 mutant was derived from the heterozygous yeast deletion collection strain, pma1Δ::KanMX4/PMA1 (Winzeler et al., 1999). The strain was transformed with a linear fragment (derived from NotI and SacII digestion of pma1-105-URA3 plasmids) containing pma1-105 marked with URA3. We chose transformants that replaced the pma1Δ::KanMX4 allele similar to a previously described strategy (Harris et al., 1994). This heterozygote was sporulated to obtain pma1-105 haploids, which were sequenced to verify the mutation. The PMA1 URA3 variant was created from the pma1Δ::KanMX4/PMA1 strain; the ura3Δ0 mutation was converted to URA3 via PCR amplification of URA3 from pRS306 and transformation. This resulting diploid strain was sporulated to obtain a PMA1 URA3 haploid. All PMA1 or pma1-105 strains that expressed other markers were created by backcrossing to these original haploids.
Strains carrying the cortical pHluorin were constructed by amplifying plasmid pADH1pr-PSR1-RMP with primers (URA3-tTA-intChr1F and R) that allowed insertion into a second empty region of chromosome 1 (17068–17161).
pKTmCherryKanMX (a kind gift from W Shou) was obtained by digestion of pKT127 (Sheff and Thorn, 2004) with PacI and BglII and insertion of the mCherry containing fragment from similarly digested pBS34. pBS34 was obtained from the Yeast Resource Center at the University of Washington with permission from R. Tsien (Shaner et al., 2004).
The GEV plasmid was previously described (Veatch et al., 2009). pAG306-GAL-PMA1chr1, was generated in two steps. First, we created pAG306-GAL-ccdBchr1, a plasmid for gene expression from the GAL promoter that can be integrated into chromosome 1 (199456–199457) after NotI digestion. We generated pAG306-GAL-ccdBchr1 by ligation of a SmaI-digested fusion PCR product that contained two ∼500-base-pair regions of chromosome 1 flanking a NotI site into AatII-digested pAG306-GAL-ccdB (Addgene plasmid 14139) (Alberti et al., 2007). We generated the fusion PCR product using oligonucleotides ChrI PartB SmaI F and ChrI PartA SmaI R to amplify two templates generated by PCR of yeast genomic DNA using oligonucleotide pairs ChrI PartA NotI F and ChrI PartA SmaI R, and ChrI PartB SmaI F and ChrI PartB NotI R, respectively. Second, we inserted PMA1 into pAG306-GAL-ccdBchr1 from donor Gateway plasmid pDONR221-PMA1 (Harvard Institute of Proteomics [HIP] accession ScCD00008895) (Hu et al., 2007), using LR Clonase according to the manufacturer's instructions (Invitrogen, Carlsbad, CA).
pAG306-GAL-PMA1-mCherryChr1 was generated by Gibson Assembly according to the manufacturer's instructions (New England Biolabs, Ipswich, MA). First PMA1-mCherry was amplified from genomic DNA from strain UCC9645 using primers GibRXNpAGdest_Pma1ChryF and GibRXNpAGdest_Pma1ChryR and assembled with a PCR product amplified from pAG306-GAL-ccdBChr1 with primers GibsonRXNpAGdstnF-2 and R-2.
pADH1pr-PSR1-RMP was derived from pADH1pr-RMP using Quikchange Site-Directed Mutagenesis (Stratagene, La Jolla, CA) to insert the first 28 amino acids of PSR1 between the ADH1 promoter and the N-terminus of RMP (ratiometric pHluorin) using primers PSR1-28-RMpHluorinF and R. pADH1pr-RMP was generated in four steps. First, pKT127-RMP was created by removing GFP from pKT127 by restriction digestion with PacI-AscI and replacing it with similarly digested RMP generated by PCR of template plasmid pGM1 (Miesenbock et al., 1998) using oligonucleotides SEP PacIF and SEP AscIR. pADH1pr-RMP was created when RMP and the ADH1 terminator were amplified with primers UPGFP/pHluorin F and R from pKT127-RMP, digested with EcoRI-EagI, and ligated into similarly digested backbone of COX4-dsREDURA3int. COX4-dsREDURA3int was created by ligating the XhoI-NotI fragment of pHS12 (Bevis and Glick, 2002) containing the ADH1 promoter and COX4 mitochondrial presequence fused to dsRED.T4 into similarly digested pRG919. pRG919 was created when a SacI-SacII PCR fragment containing a URA3 targeting construct was inserted between the SacI-SacII sites in pRS406 (Christianson et al., 1992).
The PMA1-URA plasmid was created in two steps. First, the URA3 gene was inserted downstream of the previously characterized PMA1 transcriptional termination sites (Nagalakshmi et al., 2008; Yassour et al., 2009) on chrVII (479252–479253) with primers MRKdownPma1F and MRKdownPma1R to create UCC9656. Genomic DNA from this strain was amplified with primers Pma1_1kbupNotIF and Pma1_1kbdownSacIIR to acquire a fragment containing the entire PMA1 locus plus 1 kb upstream and 1 kb downstream and URA3. This fragment was digested with NotI and SacII and ligated into similarly digested pBluescript SK+ (Stratagene). The pma1-105-URA plasmid was generated by Quikchange Site-Directed Mutagenesis (Stratagene) of the PMA1-URA plasmid using primers pma1-S368FF and pma1-S368FR.
Cells were cultured in YEPD (1% yeast extract, 2% peptone, 2% glucose) and maintained in exponential growth for 15 hr to a maximum density of 5 × 106 cells ml−1 before initiating experiments. Where indicated, cells were treated with nocodazole (Sigma, St. Louis, MO) at 10 μg ml−1 for 1.5 hr or with 5 μM β-estradiol (Sigma) for 2 hr to induce PMA1 or PMA1-mCherry overexpression.
Cells were cultured, biotin labeled, aged, and purified for quinacrine staining as previously described (Hughes and Gottschling, 2012). For cortical pH analysis of aged cells, cell labeling and purification were performed as described (Hughes and Gottschling, 2012) except incubation with streptavidin-coated magnetic beads (MicroMACS, Miltenyi Biotec, Bergisch Gladbach, Germany) and purification took place in YEPD depleted of biotin. This was achieved by overnight incubation at 4°C of 45 ml YEP with 300 μl Avidin-Agarose beads (Sigma). Glucose was added to 2%. Cells were recovered for 1 hr in YEPD prior to imaging.
Pma1 was detected by indirect immunofluorescence as described (Burke et al., 2000) using the 40B7 monoclonal antibody (Abcam, Cambridge, England) followed by Alexa Fluor 488-conjugated goat anti-mouse secondary (Invitrogen).
Quinacrine (Sigma) staining was performed as previously described (Hughes and Gottschling, 2012). In most experiments, age was determined by calcofluor (Sigma) staining of bud scars by including 5 μg ml−1 calcofluor in the last wash step before imaging. Calcoflour staining reveals bud scars (Pringle, 1991) and facilitates identification of newborn cells and the replicative age of mother cells. Calcofluor also stains the mother cell birth scar (Pringle, 1991) and allowed identification of the new mother cell during nocodazole arrest when mother cells and buds are similar in size.
Cells were imaged under ×60 oil magnification using a Nikon Eclipse E800 (Nikon, Tokyo, Japan) with the appropriate filter set: UV-2E/C DAPI for calcofluor; FITC-HYQ for quinacrine, GFP and Alexa Fluor 488; and G-2E/C TRITC for mCherry. Images were acquired with a CoolSNAP HQ2 CCD camera (Photometrics, Tucson, AZ) and Metamorph version 18.104.22.168 imaging software (Molecular Devices, Sunnyvale, CA).
Replicative lifespan was measured by micromanipulation as previously described (Hughes and Gottschling, 2012).
Cells were cultured in YEPD, but transferred to low fluorescence medium (Orij et al., 2009) for pH measurement after rinsing them in an equal volume of low fluorescence medium. Calibration curves were created as previously described (Orij et al., 2009) except that that cells were permeabilized prior to pH equilibration by treatment in 5 μg ml−1 digitonin (Sigma) in 1× PBS for 5 min. To quantify replicative age, 1 × 107 cells were stained in YEPD for 5 min with 10 μg ml−1 Wheat Germ Agglutinin-Alexa fluor 594 conjugate (Molecular Probes, Eugene, OR), washed once with an equal volume of YEPD, once with low fluorescence medium, and transferred to low fluorescence medium for 20 min prior to imaging at a density of 1 × 107 cells ml−1.
To quantify cortical pH of live single cells and to generate pH calibration curves, cells were imaged with a Leica DMI6000 B under ×63 oil magnification. Images were acquired with a Leica DFC365 FX camera and Leica Application Suite Advanced Fluorescence software (Leica, Wetzlar, Germany). TRITC excitation and emission filters (Ex525/25, Em605/52) were used to image bud scars and the combination of FITC Excitation/FITC Emission (Ex490/20, Em525/36) and DAPI Excitation/FITC Emission (Ex402/15, Em525/36) filters were used to derive cortical pH using the bimodal excitation spectrum of ratiometric pHluorin (Miesenbock et al., 1998) to calculate 402/490-nm excitation ratios. Image analysis was performed using ImageJ (Version 1.47m, NIH) to quantify mean pHluorin intensity from the identical regions of images acquired at 402 and 490 nm excitation with a 2 pixel-wide freehand line tool traced along the majority of the length of the mother cell or attached bud plasma membrane. Local background was calculated from a cell-free region one cell diameter away and subtracted from all membrane intensity measurements prior to calculation of 402/490-nm excitation ratios that were fitted to calibration curves to derive cortical pH. Statistical analyses were performed using GraphPad Prism version 4.0a software (GraphPad, La Jolla, CA).
We and others (Pineda Rodo et al., 2012) note that repeated imaging differentially affected signal intensity captured at 402 and 490 nm excitation wavelengths, which altered the excitation ratios of sequential images in a pH-independent manner. Therefore we captured a single set of images per cell and never exposed cells to excitation wavelengths prior to pHluorin imaging.
Rapidly maturing variants of the Discosoma red fluorescent protein (DsRed)Nature Biotechnology 20:83–87.https://doi.org/10.1038/nbt0102-83
Methods in yeast genetics. A Cold Spring harbor laboratory Course ManualCSHL Press.
Evidence for the involvement of a cytoplasmic factor in the aging of the yeast Saccharomyces cerevisiaeJournal of Bacteriology 171:37–42.
Growing pollen tubes possess a constitutive alkaline band in the clear zone and a growth-dependent acidic tipThe Journal of Cell Biology 144:483–496.https://doi.org/10.1083/jcb.144.3.483
The yeast Pma1 proton pump: a model for understanding the biogenesis of plasma membrane proteinsThe Journal of Biological Chemistry 276:29613–29616.https://doi.org/10.1074/jbc.R100022200
Tightly regulated, beta-estradiol dose-dependent expression system for yeastBiotechniques 29:1226–1231.
Dominant lethal mutations in the plasma membrane H(+)-ATPase gene of Saccharomyces cerevisiaeProceedings of the National Academy of Sciences of USA 91:10531–10535.https://doi.org/10.1073/pnas.91.22.10531
Daughter cells of Saccharomyces cerevisiae from old mothers display a reduced life spanThe Journal of Cell Biology 127:1985–1993.https://doi.org/10.1083/jcb.127.6.1985
Tandem fluorescent protein timers for in vivo analysis of protein dynamicsNature Biotechnology 30:708–714.https://doi.org/10.1038/nbt.2281
A mutation in the ATP2 gene abrogates the age asymmetry between mother and daughter cells of the yeast Saccharomyces cerevisiaeGenetics 162:73–87.
The yeast lysosome-like vacuole: endpoint and crossroadsBiochimica et Biophysica Acta 1793:650–663.https://doi.org/10.1016/j.bbamcr.2008.08.003
The Tem1 small GTPase controls actomyosin and septin dynamics during cytokinesisJournal of Cell Science 114:1379–1386.
Cortactin phosphorylation regulates cell invasion through a pH-dependent pathwayThe Journal of Cell Biology 195:903–920.https://doi.org/10.1083/jcb.201103045
Visualization of protein compartments within the plasma membrane of living cellsMolecular Biology of the Cell 14:4427–4436.https://doi.org/10.1091/mbc.E03-04-0221
Pleiotropic plasma membrane ATPase mutations of Saccharomyces cerevisiaeMolecular and Cellular Biology 7:4082–4088.
The mystery of aging and rejuvenation-a budding topicCurrent Opinion in Microbiology 18:61–67.https://doi.org/10.1016/j.mib.2014.02.003
Intracellular pH is a tightly controlled signal in yeastBiochimica et Biophysica Acta 1810:933–944.https://doi.org/10.1016/j.bbagen.2011.03.011
Defective H(+)-ATPase of hygromycin B-resistant pma1 mutants from Saccharomyces cerevisiaeThe Journal of Biological Chemistry 264:21857–21864.
Staining of bud scars and other cell wall chitin with calcofluorMethods in Enzymology 194:732–735.https://doi.org/10.1016/0076-6879(91)94055-H
A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiaeGenetics 122:19–27.
Psr1p/Psr2p, two plasma membrane phosphatases with an essential DXDX(T/V) motif required for sodium stress response in yeastThe Journal of Biological Chemistry 275:19352–19360.https://doi.org/10.1074/jbc.M001314200
The RAVE complex is an isoform-specific V-ATPase assembly factor in yeastMolecular Biology of the Cell 25:356–367.https://doi.org/10.1091/mbc.E13-05-0231
Identification of long-lived proteins retained in cells undergoing repeated asymmetric divisionsProceedings of the National Academy of Sciences of USA, [Epub ahead of print], 10.1073/pnas.1416079111.
Multiple methods of visualizing the yeast vacuole permit evaluation of its morphology and inheritance during the cell cycleThe Journal of Cell Biology 105:1539–1547.https://doi.org/10.1083/jcb.105.4.1539
Chance and design-proton transfer in water, channels and bioenergetic proteinsBiochimica et Biophysica Acta 1757:886–912.https://doi.org/10.1016/j.bbabio.2006.06.017
Ab initio construction of a eukaryotic transcriptome by massively parallel mRNA sequencingProceedings of the National Academy of Sciences of USA 106:3264–3269.https://doi.org/10.1073/pnas.0812841106
Karsten WeisReviewing Editor; ETH Zürich, Switzerland
eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see review process). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.
Thank you for sending your work entitled “Mother-Daughter Asymmetry of pH Underlies Aging and Rejuvenation in Yeast” for consideration at eLife. Your article has been favorably evaluated by Randy Schekman (Senior editor) and 3 reviewers, one of whom, Karsten Weis, is a member of our Board of Reviewing Editors.
The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.
In this manuscript, Henderson, Hughes, and Gottschling report on the asymmetric localization of the plasma membrane ATPase Pma1, the major proton pump in the plasma membrane of budding yeast. They show that Pma1 plays a role in establishing the asymmetry in vacuolar pH between yeast mother and daughter cells that was previously identified by the authors. They demonstrate that Pma1 is enriched at the plasma membrane of mother cells and absent from buds. This correlates with an increase in the cortical pH in the mother cell compared to the daughter, and a less acidic vacuole in the mother than in the bud. Upon over-expression of Pma1 in cells arrested in mitosis, the asymmetry of Pma1 localization is lost, and the pH asymmetry between mother and bud are reduced or lost both at the cortex and in the vacuole. Likewise, reducing the activity of Pma1 restores the lower pH in the vacuole of mother cells and extends their lifespan. Thus, the authors conclude that asymmetric distribution of Pma1 contributes to the ageing of mother cells and the formation of young daughter cells.
The referees agreed that the data are interesting and overall of good technical quality. However, there was also a consensus that some additional experiments are needed to solidify the results and the conclusion of the authors:
1) There was a concern about the low number of cells that were used in the ageing experiments (both wt and pma1-1) and the experiments seem to have been done only once. Higher numbers will be needed to evaluate the mortality of the cells as a function of age (see also point 3).
2) PMA1 mutants are long-lived and the model indicates that this is because the pH balance is altered as fewer protons are being competed for with V-ATPase to acidify the vacuole. If so, does loss of V-ATPase suppress the long lifespan of pma1 mutant yeast? Does overexpression of V-ATPase result in a long lifespan?
3) Another issue that was discussed by the reviewers concerns the interpretation of the results. Does the higher pH of the mother cell's vacuole contribute directly to ageing, or does it simply create a burden to the cell that impacts longevity? By definition ageing causes mortality (frequency of death at a certain time point) to increase with age. Thus, when the log of mortality is plotted as a function of age, the curve should have a positive linear slope. Furthermore, a process contributing to ageing should increase the slope of the curve. A rapid evaluation of the curves presented in Figure 3 suggests that in the pma1 mutant the curve is only shifted relative to the wild type and that the slope is not affected. Thus, it appears as if the pH of the vacuole modulates the time at which ageing “starts” without affecting that process itself. Furthermore, if low pH resets age in the bud, mutants with high Pma1 activity in the bud should show a shorter lifespan that decreases proportionally to the age of their mothers at the time of cytokinesis (i.e. they inherit age and cannot reset it). Alternatively, the cells might not show any difference to their mothers (everybody restarts with the same slight deficit due to the fact that ageing starts earlier for all). While the reviewers agreed that experiments addressing some of these points are laborious (but doable) these issues need to be at least discussed. Furthermore, an increase in the number of cells evaluated (see point 1) will help to get a better picture of how mortality changes with age.https://doi.org/10.7554/eLife.03504.011
1) There was a concern about the low number of cells that were used in the ageing experiments (both wt and pma1-1) and the experiments seem to have been done only once. Higher numbers will be needed to evaluate the mortality of the cells as a function of age (see also point 3).
In response to reviewers’ suggestion, we tripled the number of wild-type and pma1-105 cells whose lifespan we analyzed (now 114 and 119 cells, respectively). The additional data support our previous conclusion and are included in Figure 3C.
2) PMA1 mutants are long-lived and the model indicates that this is because the pH balance is altered as fewer protons are being competed for with V-ATPase to acidify the vacuole. If so, does loss of V-ATPase suppress the long lifespan of pma1 mutant yeast?
To address the reviewers’ suggestion, we have added lifespan analysis of strains lacking V-ATPase activity (via deletion of vma2) in the wild-type PMA1 or pma1-105 background and these data are now included in Figure 3C. The median lifespan of the vma2Δ, pma1-105 strain (7 divisions) is much shorter than wild-type (38 divisions) and more similar to the vma2Δ lifespan (2 divisions). Thus, the pma1-105 allele no longer extends lifespan in the absence of V-ATPase activity, suggesting that the ability to acidify the vacuole is required for the majority of the effect of the pma1-105 allele on lifespan. However, the vma2Δ, pma1-105 lifespan is extended (7 divisions) compared to vma2Δ lifespan (2 divisions), suggesting that the pma1-105 allele contributes additional benefits besides increased vacuole acidity. We have also added a discussion of these results to the text.
Does overexpression of V-ATPase result in a long lifespan?
We previously found the overexpression of VMA1 (a component of the V-ATPase) extends median lifespan by 40% (Hughes and Gottschling, Nature, 2012) and refer to this in the text.
3) Another issue that was discussed by the reviewers concerns the interpretation of the results. Does the higher pH of the mother cell's vacuole contribute directly to ageing, or does it simply create a burden to the cell that impacts longevity? By definition ageing causes mortality (frequency of death at a certain time point) to increase with age. Thus, when the log of mortality is plotted as a function of age, the curve should have a positive linear slope. Furthermore, a process contributing to ageing should increase the slope of the curve. A rapid evaluation of the curves presented in Figure 3 suggests that in the pma1 mutant the curve is only shifted relative to the wild type and that the slope is not affected. Thus, it appears as if the pH of the vacuole modulates the time at which ageing “starts” without affecting that process itself.
We agree with the reviewers’ comment that while the median lifespan of the pma1-105 strain is extended by 30%, the slope of the pma1-105 lifespan curve is similar to the wild-type curve and instead appears shifted compared to wild-type. We have increased the number of cells evaluated as suggested, and the slope of the wild-type and pma1-105 lifespan curves remain similar. We agree with the reviewers’ interpretation of the data that the pma1-105 allele likely delays the initiation of the events that normally occur during aging (when aging starts), rather than directly affecting the later events of aging.
We previously published that when vacuole acidity is increased during aging by VMA1 overexpression, median lifespan increases by 40% and the slope of the lifespan curve is visibly decreased compared to wild-type (Hughes and Gottschling, 2012). These findings suggest that reduced vacuole acidity contributes to aging throughout lifespan, and that increasing vacuole acidity does not simply delay the onset of the normal events of aging. The work we present here suggests that Pma1 activity influences lifespan by antagonizing vacuole acidity during aging. We therefore suspect that the pma1-105 allele simply delays the division at which vacuole acidity is reduced and that once vacuole acidity is reduced, the normal events of aging that follow occur at the normal rate. The shape of the pma1-105 lifespan curve is thus consistent with our conclusion that Pma1 activity initiates aging by reducing vacuole acidity and we have added a discussion of this idea.
Furthermore, if low pH resets age in the bud, mutants with high Pma1 activity in the bud should show a shorter lifespan that decreases proportionally to the age of their mothers at the time of cytokinesis (i.e. they inherit age and cannot reset it). Alternatively, the cells might not show any difference to their mothers (everybody restarts with the same slight deficit due to the fact that ageing starts earlier for all). While the reviewers agreed that experiments addressing some of these points are laborious (but doable) these issues need to be at least discussed. Furthermore, an increase in the number of cells evaluated (see point 1) will help to get a better picture of how mortality changes with age.
As suggested by the reviewers, we have added a discussion of the expectation that increasing Pma1 activity in buds should decrease rejuvenation.https://doi.org/10.7554/eLife.03504.012
- Daniel E Gottschling
- Daniel E Gottschling
- Adam L Hughes
- Kiersten A Henderson
- Kiersten A Henderson
- Adam L Hughes
- Adam L Hughes
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
We thank M Patel, J Roberts, and members of the Gottschling laboratory for reviewing the manuscript; A Merz for insightful discussions; G Smits, and R Orij for technical advice; G Miesenbock, J McCusker, and W Shou for reagents; and J Hsu, Z Tan, N Thayer, A Waite, and N Yazvenko for technical assistance.
- Karsten Weis, ETH Zürich, Switzerland
© 2014, Henderson et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Downloads (link to download the article as PDF)
Download citations (links to download the citations from this article in formats compatible with various reference manager tools)
Open citations (links to open the citations from this article in various online reference manager services)
A variety of microscopy techniques are used by researchers in the life and biomedical sciences. As these techniques become more powerful and more complex, it is vital that scientific articles containing images obtained with advanced microscopes include full details about how each image was obtained. To explore the reporting of such details we examined 240 original research articles published in eight journals. We found that the quality of reporting was poor, with some articles containing no information about how images were obtained, and many articles lacking important basic details. Efforts by researchers, funding agencies, journals, equipment manufacturers and staff at shared imaging facilities are required to improve the reporting of experiments that rely on microscopy techniques.
The myokine irisin facilitates muscle-bone crosstalk and skeletal remodeling in part by its action on osteoblasts and osteocytes. In the current study we investigated whether irisin also directly regulates osteoclasts. In vitro, irisin (2-10 ng/mL) increased osteoclast differentiation in C57BL/6J mouse bone marrow progenitors; this increase was blocked by a neutralizing antibody to integrin αVβ5. Irisin also increased bone resorption on several substrates in situ. RNAseq revealed differential gene expression induced by irisin including upregulation of markers for osteoclast differentiation and resorption, as well as osteoblast-stimulating 'clastokines'. Forced expression of the irisin precursor Fndc5 in transgenic C57BL/6J mice resulted in low bone mass at three ages, and greater in vitro osteoclastogenesis from Fndc5-transgenic bone marrow progenitors. This work demonstrates that irisin acts directly on osteoclast progenitors to increase differentiation and promote bone resorption, supporting the tenet that irisin not only stimulates bone remodeling but may also be an important counter-regulatory hormone.